← Nurses CPD
Lung Cancer Diagnosis and Treatment - The Impact of PET Imaging and Targeted Therapies
Please be informed that participation in the post-test assessment is mandatory for the issuance of certificates and the allocation of associated CPD points when finalized. Completion and passing of the post-test are required to validate your attendance and ensure compliance with CPD accreditation requirements for this session. Thank you for your cooperation and commitment to professional development.
PET Imaging & Targeted Therapies in Cancer: A Masterclass Series
SESSION FOUR: Lung Cancer Diagnosis and Treatment: The Impact of PET Imaging and Targeted Therapies
This session delves into the pivotal role of PET imaging in the diagnosis, staging, and treatment of lung cancer. Participants will explore how PET scans enhance early detection and provide critical insights into treatment efficacy, enabling clinicians to make more accurate decisions throughout the care continuum. Additionally, the session will examine the use of targeted therapies in lung cancer, highlighting how PET imaging can guide the tailoring of these therapies for optimal patient outcomes. Leading experts in the field will share their knowledge and real-world experience to illustrate the integration of PET imaging with cutting-edge targeted treatment strategies.
SESSION BREAKDOWN
Each individual topic in the series has been carefully crafted to build on the knowledge acquired in previous sessions while allowing participants to engage deeply with each aspect of PET imaging and targeted therapies in cancer. The topics include:
Session 1: The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care
Session 2: Enhancing Breast Cancer Management through PET Scans and Targeted Therapies
Session 3: PET Imaging and Targeted Therapies in Hematological Malignancies
Session 4: Lung Cancer Diagnosis and Treatment: The Impact of PET Imaging and Targeted Therapies
Session 5: Prostate Cancer Management: The Role of PET Imaging and Advanced Therapies
EARN CPD POINTS
Participants will earn valuable CPD points upon successful completion of each session, supporting their continuous professional development and helping them stay at the forefront of advancements in cancer care. This credentialing underscores the commitment of SGMC to foster professional growth and knowledge enhancement in the medical community, ensuring that participants are recognized for their dedication to advancing patient outcomes.
WHY REGISTER AND ATTEND THIS TRAINING SERIES?
This masterclass series offers a unique opportunity to learn from renowned experts and gain cutting-edge knowledge in the rapidly evolving field of cancer diagnostics and treatment. Whether you're an oncologist, radiologist, or healthcare professional interested in oncology, attending these sessions will provide you with practical insights and the latest research to elevate patient care. Participants will also benefit from an interactive format, engaging directly with facilitators and peers through thought-provoking discussions and Q&A sessions.
SESSION 3: PET Imaging and Targeted Therapies in Hematological Malignancies
This session focuses on the pivotal role of PET imaging in the diagnosis, staging, and treatment monitoring of hematological malignancies, including lymphoma and leukemia. Participants will gain insights into the integration of PET scans into clinical workflows, enhancing the accuracy of disease detection and therapeutic response evaluation. Additionally, the session explores advancements in targeted treatments for hematological cancers and how PET imaging aids in optimizing these therapies. Facilitated by leading experts, this interactive session is designed to empower participants with cutting-edge knowledge and practical strategies to enhance outcomes in hematological.
ORGANIZED BY
PROUDLY SPONSORED BY
This virtual training will premier on Thursday the 12th of December 2024 at 4:00 PM.
Target Audience: Medical Doctors, Pharmacists, Nurses and Radiotherapists
Moderator: Dr. Amankwaa Frempong
Date: Thursday 12th December 2024
Time: 16:00 GMT (4:00 pm local time)
AGENDA
Thursday 12th December 2024 (VIRTUAL EVENT)
Overview
Course Description
The MASTERCLASS IN PET IMAGING & TARGETED THERAPIES FOR CANCER CARE begins with a foundational session, THE SIGNIFICANCE OF PET SCANS IN ONCOLOGY – A CORNERSTONE OF MODERN CANCER CARE. This session focuses on the pivotal role of PET imaging in the diagnosis, staging, and treatment monitoring of hematological malignancies, including lymphoma and leukemia. Participants will gain insights into the integration of PET scans into clinical workflows, enhancing the accuracy of disease detection and therapeutic response evaluation. Additionally, the session explores advancements in targeted treatments for hematological cancers and how PET imaging aids in optimizing these therapies. Facilitated by leading experts, this interactive session is designed to empower participants with cutting-edge knowledge and practical strategies to enhance outcomes in hematological
What you will learn
At the end of this training, participants will be able to:
1. Understand the role of PET imaging in early detection and accurate staging of lung cancer.
2. Evaluate the use of PET scans for assessing treatment response in lung cancer.
3. Examine the integration of PET imaging in personalized lung cancer treatment planning.
4. Identify the benefits of using PET imaging to guide the selection of targeted therapies in lung cancer.
5. Discuss the clinical impact of PET-guided targeted therapies on lung cancer patient outcomes.
Course Content
Lecture Sessions
- LIVE EVENT: Thursday 12th December 2024 from 1600 GMT (4:00 pm) 2 hours
Downloadables
No downloadable content added to this course yet.
Steps to Join Course
About Facilitators
- 1 Course on CES
Dr. Clement Egyin Edusa
MD, IAEA Fellowship
CEO and Clinical/Radiation Oncologist
Sweden Ghana Medical Center (SGMC)
Dr. Clement Egyin Edusa is a distinguished Clinical and Radiation Oncologist with an illustrious career spanning leadership, clinical practice, research, and community service. Currently serving as the CEO and Clinical/Radiation Oncologist at the Sweden Ghana Medical Center (SGMC), he has made significant contributions to oncology care and management.
View full profile / courses
- 1 Course on CES
Dr. Verna Delaenam Naa Kwadua Vanderpuye
MB ChB, FWACS, FGCP, FASCO
Deputy Director | Consultant Radiation and Clinical Oncologist | Professor(Adjunct),
National Center for Radiotherapy and Oncology - Accra, Ghana | Dept of Oncology, Queens University, Kingston ON. Canada
Verna Delaenam Naa Kwadua Vanderpuye is a distinguished Consultant Radiation and Clinical Oncologist currently serving as the Deputy Director of the National Center for Radiotherapy and Oncology in Accra, Ghana. She also holds an adjunct professorship at the Department of Oncology at Queen’s University in Kingston, Ontario, Canada.
View full profile / coursesRelated Courses
